Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph M Herman

Showing results (301-310 of 316) with videos related to

Pageof 32
Sort By:
Cancer|December 25, 2014
Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinomaJoseph M Herman, Daniel T Chang, Karyn A Goodman, et al.
Endoscopic Ultrasound|November 1, 2019
An open-label, single-arm pilot study of EUS-guided brachytherapy with phosphorus-32 microparticles in combination with gemcitabine +/- nab-paclitaxel in unresectable locally advanced pancreatic cancer (OncoPaC-1): Technical details and study protocolManoop S Bhutani, Jason B Klapman, Richard Tuli, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2019
Proton beam therapy outcomes for localized unresectable hepatocellular carcinomaAwalpreet S Chadha, Jillian R Gunther, Cheng-En Hsieh, et al.
BMC Cancer|June 13, 2019
Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survivalAlessio G Morganti, Francesco Cellini, Milly Buwenge, et al.
International Journal of Radiation Oncology, Biology, Physics|November 22, 2017
Multiplex Proximity Ligation Assay to Identify Potential Prognostic Biomarkers for Improved Survival in Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Radiation TherapyAvani D Rao, Yufei Liu, Rie von Eyben, et al.
Videogie : an Official Video Journal of the American Society for Gastrointestinal Endoscopy|May 9, 2019
Novel EUS-guided brachytherapy treatment of pancreatic cancer with phosphorus-32 microparticles: first United States experienceManoop S Bhutani, Irina M Cazacu, Alexandra A Luzuriaga Chavez, et al.
Journal of Hepatocellular Carcinoma|March 10, 2021
Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with RadiotherapyBrian De, Sweet Ping Ng, Amy Y Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2009
SMAD4 gene mutations are associated with poor prognosis in pancreatic cancerAmanda Blackford, Oscar K Serrano, Christopher L Wolfgang, et al.
Annals of Surgery|August 16, 2022
Pancreatic Cancer Patient-derived Organoids Can Predict Response to Neoadjuvant ChemotherapyLyudmyla Demyan, Amber N Habowski, Dennis Plenker, et al.
Cancer|January 26, 2018
Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapyAhmed M Amer, Mohamed Zaid, Baishali Chaudhury, et al.
Pageof 32

Showing results (301-310 of 316) with videos related to

Sort By:
Pageof 32
Cancer|December 25, 2014
Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinomaJoseph M Herman, Daniel T Chang, Karyn A Goodman, et al.
Endoscopic Ultrasound|November 1, 2019
An open-label, single-arm pilot study of EUS-guided brachytherapy with phosphorus-32 microparticles in combination with gemcitabine +/- nab-paclitaxel in unresectable locally advanced pancreatic cancer (OncoPaC-1): Technical details and study protocolManoop S Bhutani, Jason B Klapman, Richard Tuli, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2019
Proton beam therapy outcomes for localized unresectable hepatocellular carcinomaAwalpreet S Chadha, Jillian R Gunther, Cheng-En Hsieh, et al.
BMC Cancer|June 13, 2019
Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survivalAlessio G Morganti, Francesco Cellini, Milly Buwenge, et al.
International Journal of Radiation Oncology, Biology, Physics|November 22, 2017
Multiplex Proximity Ligation Assay to Identify Potential Prognostic Biomarkers for Improved Survival in Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Radiation TherapyAvani D Rao, Yufei Liu, Rie von Eyben, et al.
Videogie : an Official Video Journal of the American Society for Gastrointestinal Endoscopy|May 9, 2019
Novel EUS-guided brachytherapy treatment of pancreatic cancer with phosphorus-32 microparticles: first United States experienceManoop S Bhutani, Irina M Cazacu, Alexandra A Luzuriaga Chavez, et al.
Journal of Hepatocellular Carcinoma|March 10, 2021
Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with RadiotherapyBrian De, Sweet Ping Ng, Amy Y Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2009
SMAD4 gene mutations are associated with poor prognosis in pancreatic cancerAmanda Blackford, Oscar K Serrano, Christopher L Wolfgang, et al.
Annals of Surgery|August 16, 2022
Pancreatic Cancer Patient-derived Organoids Can Predict Response to Neoadjuvant ChemotherapyLyudmyla Demyan, Amber N Habowski, Dennis Plenker, et al.
Cancer|January 26, 2018
Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapyAhmed M Amer, Mohamed Zaid, Baishali Chaudhury, et al.
Pageof 32